Do efforts to decrease door-to-needle time risk increasing stroke mimic treatment rates?

Ava Leigh Liberman, Eric M. Liotta, Fan Z. Caprio, Ilana Ruff, Matthew B. Maas, Richard A. Bernstein, Rahul Khare, Deborah Bergman, Shyam Prabhakaran

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Summary An unintended consequence of rapid thrombolysis may be more frequent treatment of stroke mimics, nonvascular conditions that simulate stroke. We explored the relationship between door-to-needle (DTN) times and thrombolysis of stroke mimics at a single academic center by analyzing consecutive quartiles of patients who were treated with IV tissue plasminogen activator for suspected stroke from January 1, 2010 to February 28, 2014. An increase in the proportion of stroke mimic patients (6.7% in each of the 1st and 2nd, 12.9% in the 3rd, and 30% in the last consecutive case quartile; p 0.03) and a decrease in median DTN time from 89 to 56 minutes (p < 0.01) was found. As more centers reduce DTN times, the rates of stroke mimic treatment should be carefully monitored.

Original languageEnglish (US)
Pages (from-to)247-252
Number of pages6
JournalNeurology: Clinical Practice
Volume5
Issue number3
DOIs
StatePublished - Jun 10 2015
Externally publishedYes

Fingerprint

Needles
Stroke
Therapeutics
Tissue Plasminogen Activator

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Liberman, A. L., Liotta, E. M., Caprio, F. Z., Ruff, I., Maas, M. B., Bernstein, R. A., ... Prabhakaran, S. (2015). Do efforts to decrease door-to-needle time risk increasing stroke mimic treatment rates? Neurology: Clinical Practice, 5(3), 247-252. https://doi.org/10.1212/CPJ.0000000000000122

Do efforts to decrease door-to-needle time risk increasing stroke mimic treatment rates? / Liberman, Ava Leigh; Liotta, Eric M.; Caprio, Fan Z.; Ruff, Ilana; Maas, Matthew B.; Bernstein, Richard A.; Khare, Rahul; Bergman, Deborah; Prabhakaran, Shyam.

In: Neurology: Clinical Practice, Vol. 5, No. 3, 10.06.2015, p. 247-252.

Research output: Contribution to journalArticle

Liberman, AL, Liotta, EM, Caprio, FZ, Ruff, I, Maas, MB, Bernstein, RA, Khare, R, Bergman, D & Prabhakaran, S 2015, 'Do efforts to decrease door-to-needle time risk increasing stroke mimic treatment rates?', Neurology: Clinical Practice, vol. 5, no. 3, pp. 247-252. https://doi.org/10.1212/CPJ.0000000000000122
Liberman, Ava Leigh ; Liotta, Eric M. ; Caprio, Fan Z. ; Ruff, Ilana ; Maas, Matthew B. ; Bernstein, Richard A. ; Khare, Rahul ; Bergman, Deborah ; Prabhakaran, Shyam. / Do efforts to decrease door-to-needle time risk increasing stroke mimic treatment rates?. In: Neurology: Clinical Practice. 2015 ; Vol. 5, No. 3. pp. 247-252.
@article{23268156b788480eb83d51a181fd2400,
title = "Do efforts to decrease door-to-needle time risk increasing stroke mimic treatment rates?",
abstract = "Summary An unintended consequence of rapid thrombolysis may be more frequent treatment of stroke mimics, nonvascular conditions that simulate stroke. We explored the relationship between door-to-needle (DTN) times and thrombolysis of stroke mimics at a single academic center by analyzing consecutive quartiles of patients who were treated with IV tissue plasminogen activator for suspected stroke from January 1, 2010 to February 28, 2014. An increase in the proportion of stroke mimic patients (6.7{\%} in each of the 1st and 2nd, 12.9{\%} in the 3rd, and 30{\%} in the last consecutive case quartile; p 0.03) and a decrease in median DTN time from 89 to 56 minutes (p < 0.01) was found. As more centers reduce DTN times, the rates of stroke mimic treatment should be carefully monitored.",
author = "Liberman, {Ava Leigh} and Liotta, {Eric M.} and Caprio, {Fan Z.} and Ilana Ruff and Maas, {Matthew B.} and Bernstein, {Richard A.} and Rahul Khare and Deborah Bergman and Shyam Prabhakaran",
year = "2015",
month = "6",
day = "10",
doi = "10.1212/CPJ.0000000000000122",
language = "English (US)",
volume = "5",
pages = "247--252",
journal = "Neurology: Clinical Practice",
issn = "2163-0402",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Do efforts to decrease door-to-needle time risk increasing stroke mimic treatment rates?

AU - Liberman, Ava Leigh

AU - Liotta, Eric M.

AU - Caprio, Fan Z.

AU - Ruff, Ilana

AU - Maas, Matthew B.

AU - Bernstein, Richard A.

AU - Khare, Rahul

AU - Bergman, Deborah

AU - Prabhakaran, Shyam

PY - 2015/6/10

Y1 - 2015/6/10

N2 - Summary An unintended consequence of rapid thrombolysis may be more frequent treatment of stroke mimics, nonvascular conditions that simulate stroke. We explored the relationship between door-to-needle (DTN) times and thrombolysis of stroke mimics at a single academic center by analyzing consecutive quartiles of patients who were treated with IV tissue plasminogen activator for suspected stroke from January 1, 2010 to February 28, 2014. An increase in the proportion of stroke mimic patients (6.7% in each of the 1st and 2nd, 12.9% in the 3rd, and 30% in the last consecutive case quartile; p 0.03) and a decrease in median DTN time from 89 to 56 minutes (p < 0.01) was found. As more centers reduce DTN times, the rates of stroke mimic treatment should be carefully monitored.

AB - Summary An unintended consequence of rapid thrombolysis may be more frequent treatment of stroke mimics, nonvascular conditions that simulate stroke. We explored the relationship between door-to-needle (DTN) times and thrombolysis of stroke mimics at a single academic center by analyzing consecutive quartiles of patients who were treated with IV tissue plasminogen activator for suspected stroke from January 1, 2010 to February 28, 2014. An increase in the proportion of stroke mimic patients (6.7% in each of the 1st and 2nd, 12.9% in the 3rd, and 30% in the last consecutive case quartile; p 0.03) and a decrease in median DTN time from 89 to 56 minutes (p < 0.01) was found. As more centers reduce DTN times, the rates of stroke mimic treatment should be carefully monitored.

UR - http://www.scopus.com/inward/record.url?scp=84930705505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930705505&partnerID=8YFLogxK

U2 - 10.1212/CPJ.0000000000000122

DO - 10.1212/CPJ.0000000000000122

M3 - Article

AN - SCOPUS:84930705505

VL - 5

SP - 247

EP - 252

JO - Neurology: Clinical Practice

JF - Neurology: Clinical Practice

SN - 2163-0402

IS - 3

ER -